Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 29;13(5):1079.
doi: 10.3390/biomedicines13051079.

The Effects of the Biological Agents Infliximab, Vedolizumab, and Ustekinumab on Intestinal Anastomosis: An Experimental Study in Rats

Alexandra Menni  1 , Georgios Tzikos  1 , Patroklos Goulas  1 , George Chatziantoniou  1 , Angeliki Vouchara  1 , Athanasios S Apostolidis  1   2 , Aristeidis Ioannidis  1 , Georgios Germanidis  3 , Lyssimachos G Papazoglou  4 , Olga Giouleme  5 , Stylianos Apostolidis  1
Affiliations

The Effects of the Biological Agents Infliximab, Vedolizumab, and Ustekinumab on Intestinal Anastomosis: An Experimental Study in Rats

Alexandra Menni et al. Biomedicines. .

Abstract

Background/Objectives: The potential side effects of the use of biological agents in the perioperative period are still under investigation. This animal prospective study aimed to evaluate the overall impact of biological factor administration after intestinal surgery. Methods: This study included 80 female Wistar rats sorted into four groups: three groups received one of the biological factors, infliximab, vedolizumab, or ustekinumab; the control group received placebo therapy. After enterotomy and intestinal anastomosis, the bursting pressure (BP) of the anastomosis was compared among the groups on postoperative days (PODs) 3 and 7. Results: On POD3, the control group presented with a significantly higher mean BP (154.6 ± 39.7 mmHg) compared to the infliximab (66.8 ± 10.4 mmHg), vedolizumab (105.4 ± 37.6 mmHg), and ustekinumab (98.8 ± 47.9 mmHg) groups. A post hoc analysis among the three biological agent groups revealed differences only when comparing infliximab and vedolizumab rats with the controls on POD3 (p < 0.001) and with the ustekinumab rats on POD7, having a greater mean BP (282.5 ± 80.1 mmHg, p = 0.031). No differences were observed regarding the event of broken anastomosis among the four groups. Conclusions: This experimental study's findings highlight the varying detrimental effects of different biological agents on the strength of intestinal anastomosis, with ustekinumab demonstrating superior performance.

Keywords: IBDs; biological agents; experimental study; infliximab; surgical complications; ustekinumab; vedolizumab.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Excised part of intestine containing anastomosis (marked with arrow).
Figure 2
Figure 2
Bursting pressure measurement setting.
Scheme 1
Scheme 1
BP on postoperative day 3.
Scheme 2
Scheme 2
BP on postoperative day 7.
Scheme 3
Scheme 3
BP difference between postoperative days 3 and 7.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Lawson M.M., Thomas A.G., Akobeng A.K. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev. 2006;3:Cd005112. doi: 10.1002/14651858.CD005112.pub2. - DOI - PubMed
    1. Mor I.J., Vogel J.D., da Luz Moreira A., Shen B., Hammel J., Remzi F.H. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis. Colon Rectum. 2008;51:1202–1207. doi: 10.1007/s10350-008-9364-7. - DOI - PubMed
    1. Poritz L.S., Rowe W.A., Koltun W.A. Remicade does not abolish the need for surgery in fistulizing Crohn’s disease. Dis. Colon Rectum. 2002;45:771–775. doi: 10.1007/s10350-004-6296-8. - DOI - PubMed
    1. Verhofstad M.H., Lange W.P., van der Laak J.A., Verhofstad A.A., Hendriks T. Microscopic analysis of anastomotic healing in the intestine of normal and diabetic rats. Dis. Colon Rectum. 2001;44:423–431. doi: 10.1007/BF02234744. - DOI - PubMed
    1. Inan A., Koca C., Sen M. Effects of diclofenac sodium on bursting pressures of anastomoses and hydroxyproline contents of perianastomotic tissues in a laboratory study. Int. J. Surg. 2006;4:222–227. doi: 10.1016/j.ijsu.2006.01.002. - DOI - PubMed

LinkOut - more resources